Shuhei Hara
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapy.
Journal: International journal of clinical oncology
Published: April 29, 2026
Beyond PSA90: Deep PSA response predicts outcomes in nonmetastatic CRPC.
Journal: Urologic oncology
Published: February 11, 2026
Real-World Effectiveness and Treatment Persistence of Darolutamide, Apalutamide, and Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Study.
Journal: Clinical genitourinary cancer
Published: January 10, 2026
Clinical Characteristics and Predictive Factors of Symptomatic Skeletal Events in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Denosumab.
Journal: Clinical genitourinary cancer
Published: December 30, 2025
Worsening Diabetic Retinopathy With GLP-1 Receptor Agonists in Kidney Transplant Recipients: An Emerging Signal Requiring Ophthalmologic Vigilance.
Journal: Clinical transplantation
Published: December 22, 2025
Tumor cell invasion of blood vessels predicts poor survival in upper tract urothelial carcinoma following radical nephroureterectomy.
Journal: Japanese journal of clinical oncology
Published: December 11, 2025
Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumab.
Journal: International journal of clinical oncology
Published: September 26, 2025
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort study.
Journal: Translational andrology and urology
Published: August 27, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort study.
Journal: Japanese journal of clinical oncology
Published: August 25, 2025
Predicting recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: Development and validation of the JIKEI-YAYOI score.
Journal: Urologic oncology
Published: May 23, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective study.
Journal: Japanese journal of clinical oncology
Published: February 27, 2025
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study.
Journal: Prostate international
Published: October 21, 2024
Last Updated: 09/26/2026